U.S. and Japanese authorities have approved filings for Bristol Myers Squibb's Breyanzi, aimed at treating recurrent Follicular and Mantle Cell Lymphomas.

Viagra relaxes muscles found in the walls of blood vessels and increases blood flow to particular areas of the body.

Vertex Reveals Encouraging Outcomes from Phase 3 Trials of VX-548 for Moderate to Intense Short-Term Pain Management.

Citalopram was approved for medical use in the United States in 1998. It is on the World Health Organization's List of Essential Medicines.

CellVax Therapeutics has received approval from the FDA for its IND submission for FK-PC101, a new individualized immunotherapy treatment for cancer.

Clonidine lowers blood pressure by stimulating α2 receptors in the brain, which results in relaxation of many arteries.

DP Tech has revealed its selection of a developmental contender, a promising top-tier Kv1.3 blocker aimed at tackling immune disorders like IBD and AD.

SINGULAIR® (Montelukast sodium) is a drug for treating asthma, exercise-induced bronchoconstriction (EIB), and allergic rhinitis.

EicOsis Human Health has announced the advancement of its clinical research program, beginning a Phase 1b trial to assess the safety of its experimental drug, EC5026, through increasing dosages.

Finasteride, sold as PROSCAR®, is a 5α-reductase inhibitor mainly used to treat men with benign prostatic hyperplasia (BPH) symptoms with enlarged prostates.

EMA evaluates GSK's Arexvy, an RSV immunization, for approval to protect adults 50-59 with high risk from RSV infection.

Baclofen, sold under the brand name Lioresal among others, is a medication used to treat muscle spasticity such as from a spinal cord injury or multiple sclerosis.